Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection

被引：0
|
作者：
Hala Mohsen Abdullatif
Rania Ramzi
Engy Adel Mogahed
Carolyne Morcos Ghobrial
Basma Abd El Rasheed Abd El Zaher
Mona S. El Raziky
Hanaa Mostafa El-Karaksy
机构：
[1] Cairo University Pediatric Hospital,Pediatric Hepatology Unit
[2] Kasr Alainy Drug Information Center,undefined
[3] Cairo University,undefined
来源：
Clinical Drug Investigation | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 864
页数：7
相关论文
共 50 条
  • [21] An evaluation of ledipasvir plus sofosbuvir for the treatment of chronic hepatitis C infection
    Balatow, Pearson
    Sandlin, Amber
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (14) : 1839 - 1846
  • [22] Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
    Sundaram, Vinay
    Kowdley, Kris V.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 75 - 80
  • [23] Sofosbuvir treatment and hepatitis C virus infection
    Nakamura, Masato
    Kanda, Tatsuo
    Haga, Yuki
    Sasaki, Reina
    Wu, Shuang
    Nakamoto, Shingo
    Yasui, Shin
    Arai, Makoto
    Imazeki, Fumio
    Yokosuka, Osamu
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (03) : 183 - 190
  • [24] Sofosbuvir for the treatment of hepatitis C virus infection
    Rolland, Sebastien
    Vachon, Marie-Louise
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2015, 187 (03) : 203 - 204
  • [25] Sofosbuvir treatment and hepatitis C virus infection
    Masato Nakamura
    Tatsuo Kanda
    Yuki Haga
    Reina Sasaki
    Shuang Wu
    Shingo Nakamoto
    Shin Yasui
    Makoto Arai
    Fumio Imazeki
    Osamu Yokosuka
    World Journal of Hepatology, 2016, (03) : 183 - 190
  • [26] Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naïve Children without and with Comorbidities
    Othman AbouBakr
    Mohammed Ezz El Regal
    Amr Ali Sarhan
    Maysaa El Sayed Zaki
    Ahmed Noaman
    Pediatric Drugs, 2022, 24 : 529 - 537
  • [27] Pharmacokinetic and Safety Study of Ledipasvir/Sofosbuvir Treatment in Pregnant Women with Chronic Hepatitis C Virus Infection
    Chappell, Catherine A.
    Scarsi, Kimberly K.
    Kirby, Brian J.
    Suri, Vithika
    Gaggar, Anuj
    Krans, Elizabeth E.
    Macio, Ingrid S.
    Meyn, Leslie A.
    Bogen, Debra L.
    Bunge, Katherine E.
    Hillier, Sharon L.
    JOURNAL OF WOMENS HEALTH, 2019, 28 (11) : 1582 - 1582
  • [28] LEDIPASVIR/SOFOSBUVIR FIXED-DOSE COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS GENOTYPE 4 INFECTION
    Nehra, V.
    Tan, E. M.
    Rizza, S. A.
    Temesgen, Z.
    DRUGS OF TODAY, 2016, 52 (02) : 111 - 117
  • [29] A pharmacokinetic and treatment study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus
    Chappell, C.
    Kirby, B.
    Scarsi, K.
    Suri, V.
    Gaggar, A.
    Krans, E.
    Macio, I.
    Meyn, L.
    Bogen, D.
    Bunge, K.
    Hillier, S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (06) : 666 - 666
  • [30] Hepatitis C virus infection: accessing drug treatment
    Smyth, Dan
    Webster, Duncan
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2015, 187 (15) : 1113 - 1114
12345